Mark A. Espeland
Physiology · 2003–2016
A researcher in the Science corpus: 7 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 19 citations into it
- Molecular Biology — 15 citations into it
- Aging — 9 citations into it
Whom Mark A. Espeland trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Mark A. Espeland overall
Papers from Mark A. Espeland's perspective
Ordered by how strongly the researchers Mark A. Espeland trusts endorse each paper. Same corpus, a different order for every researcher.
- Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
- Silent brain infarcts and the risk of dementia and cognitive decline. (New England Journal of Medicine)
- Estrogen and cognitive functioning in women. (Endocrine reviews)
- Effects of estrogen plus progestin on health-related quality of life. (New England Journal of Medicine)
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice (Nature)
- Metformin Induces a Dietary Restriction–Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1 (PLoS ONE)
- mTOR is a key modulator of ageing and age-related disease (Nature)
- New Users of Metformin Are at Low Risk of Incident Cancer (Diabetes Care)
- Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism (Cell)
- Perceived Exertion (Sports Medicine)
Their papers
- Metformin as a Tool to Target Aging (2016) — 967 citations
- Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE Study randomized clinical trial (2014) — 1,306 citations
- Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. (2013) — 1,723 citations
- Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes (2007) — 1,589 citations
- Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. (2004) — 822 citations
- Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. (2003) — 738 citations
- Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. (2003) — 954 citations